Brilliant Violet 605™ anti-mouse Ly-6C Antib
- 产品名称:
- Brilliant Violet 605™ anti-mouse Ly-6C Antib
- 产品类别:
- 抗体
- 产品编号:
- 128035
- 产品应用:
- 128035
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- L3 cloned CTL cells
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
- Preparation
- The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 605? under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.
Brilliant Violet 605? excites at 405 nm and emits at 603 nm. The bandpass filter 610/20 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 605? is a trademark of Sirigen Group Ltd.
Learn more about Brilliant Violet?.
This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents. - Excitation Laser
- Violet Laser (405 nm)
- Application Notes
Clone HK1.4 does not block the binding of clone RB6-8C58.
Additional reported applications (for relevant formats of this clone) include: in vitro activation of T cells1-3 and immunohistochemistry of frozen sections4.
- Application References
(PubMed link indicates BioLegend citation) -
- Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (Activ)
- Herold KC, et al. 1990. Diabetes 39:815. (Activ)
- Havran WL, et al. 1988. J. Immunol. 140:1034 (Activ)
- Flanagan K, et al. 2008. J. Immunol. 180:3874. (IHC)
- Makaroff LE, et al. 2009. P. Natl. Acad. Sci. USA 106:4799. (FC)
- Zuber J, et al. 2009. Genes Dev. 23:877. (FC) PubMed
- Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
- Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
- Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
- Product Citations
-
- Miranda K, et al. 2022. iScience. 25:104994. PubMed
- Wilden A, et al. 2022. Front Immunol. 13:991295. PubMed
- Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
- Sierro F, et al. 2017. Immunity. 47:374. PubMed
- Alkhani A, et al. 2020. Sci Rep. 10:7165. PubMed
- Gawish R, et al. 2022. Elife. 11:. PubMed
- Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
- Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
- Han SJ et al. 2017. Immunity. 47(6):1154-1168 . PubMed
- Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
- Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed
- Yousif AS, et al. 2020. Immunity. 54(2):235-246.e5. PubMed
- Leech JM, et al. 2020. Cell Host & Microbe. 26(6):795-809.e5.. PubMed
- Hering L, et al. 2021. Int J Mol Sci. 22:. PubMed
- Starkl P, et al. 2020. Immunity. 53(4):793-804.e9. PubMed
- Kosack L, et al. 2017. Sci Rep. 7:11289. PubMed
- Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
- Kedage V, et al. 2022. MAbs. 14:2040083. PubMed
- Huang X, et al. 2020. Cell Host Microbe. 29(2):210-221.e6. PubMed
- Lebratti T, et al. 2021. eLife. 10:00. PubMed
- Zhou Y, et al. 2020. Immunity. 52(2):357-373. PubMed
- Kimball A, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1102. PubMed
- Goggi JL, et al. 2020. Mol Imaging Biol. 22:1392. PubMed
- Salei N, et al. 2020. J Am Soc Nephrol. 31:257. PubMed
- Tuttle KD, et al. 2020. Cell Rep. 33:108407. PubMed
- Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed
- Progatzky F, et al. 2021. Nature. 599:125. PubMed
- Wessel AW, et al. 2020. Nat Commun. 4.123611111. PubMed
- Linehan JL et al. 2018. Cell. 172(4):784-796 . PubMed
- Tondini E, et al. 2022. NPJ Vaccines. 7:64. PubMed
- Garland KM, et al. 2021. Front Immunol. 12:753472. PubMed
- Hassan AO, et al. 2021. Cell Reports. 36(4):109452. PubMed
- Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
- Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
- Sefik E, et al. 2021. Nat Biotechnol. . PubMed
- Da Silva CG, et al. 2019. Theranostics. 4.878472222. PubMed
- Cohen M et al. 2018. Cell. 175(4):1031-1044 . PubMed
- Robles-Oteiza C, et al. 2021. Dis Model Mech. 14:. PubMed
- Nair S, et al. 2021. JCI Insight. 6:. PubMed
- Winkler ES, et al. 2020. Nat Immunol. 21:1327. PubMed
- Stacy A, et al. 2021. Cell. 184(3):615-627.e17. PubMed
- Giampazolias E, et al. 2021. Cell. . PubMed
- Alam Z, et al. 2020. Cell Rep. 107825:31. PubMed
- Beura LK, et al. 2018. Immunity. 48:327. PubMed
- Su W et al. 2019. Cancer Cell. 36(2):139-155 . PubMed
- Blagih J, et al. 2020. Cell Rep. 30:481. PubMed
- Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
- Lam KC, et al. 2021. Cell. 184:5338. PubMed
- Kimball AS, et al. 2020. Thromb Haemost. 120:289. PubMed
- Lai SM et al. 2018. Cell reports. 25(11):3099-3109 . PubMed
- Soncin I, et al. 2018. Nat Commun. 9:582. PubMed
- Xiao Y, et al. 2021. Cell. 184:6037. PubMed
- Katzmarski N, et al. 2021. Nat Immunol. 22:1382. PubMed
- Hering L, et al. 2020. Front Immunol. 1.747222222. PubMed
- Hayashida E, et al. 2019. J Neuroinflammation. 0.789583333. PubMed
- Boulch M, et al. 2021. Sci Immunol. 6:. PubMed
- Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed
- Sheng J, et al. 2021. eLife. 10:00. PubMed
- Mathur AN, et al. 2019. Immunity. 50:655. PubMed
- Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
- Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
- Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
- Perez-Cruz M, et al. 2021. PLoS One. e0236216:16. PubMed
- Young K, et al. 2021. Cell Stem Cell. . PubMed
- Maas SLN, et al. 2020. J Neuroinflammation. 17:120. PubMed
- Ershaid N, et al. 2019. Nat Commun. 10:4375. PubMed
- Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
- Di Liberto G et al. 2018. Cell. 175(2):458-471 . PubMed
- RRID
- AB_2562352 (BioLegend Cat. No. 128035) AB_2562353 (BioLegend Cat. No. 128036)
- Structure
- 14-17 kD protein (134 amino acids), member of the Ly-6 family of GPI linked protein. Ly6 family members share structure homology throughout a distinctive cystein rich protein domain that incorporates O-linked carbohydrates.
- Distribution
-
Ly-6C is expressed primarily on bone marrow myeloid populations, monocytes/macrophages, neutrophils, endothelial cells, and some T cell subsets. Ly-6C is also a marker of memory CD8+ T cells.
- Cell Type
- Endothelial cells, Macrophages, Monocytes, Neutrophils, T cells
- Biology Area
- Immunology
- Molecular Family
- CD Molecules
- Antigen References
-
1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
2. Cerwenka A, et al. 1998. J. Immunol. 161:97.
- Gene ID
- 17067 View all products for this Gene ID
- UniProt
- View information about Ly-6C on UniProt.org